Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ARQT · against 258 other Healthcare companies of similar size
Ranked #210 of 259 · scores higher than 19% of peers · safety percentile 23
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)23 peers with a safety percentile of 20–29, including ARQT · Click a bar to see the companies
Mainly because of its beta and debt / equity, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | ARQT | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 254 reported | 0.52× | 0.25× | 28% | 33% | |
| BetaLower is better · 255 reported | 1.58 | 0.55 | 11% | 33% | |
| Current ratioHigher is better · 249 reported | 2.92× | 2.49× | 54% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 2.6B USD | 100 | 43 | |
| 4 | 3.6B USD | 99 | ||
| 5 | 2.2B USD | 99 | 48 | |
| 206 | 73.5B TRY (≈$2.2B) | 24 | 68 | |
| 207 | 3.4B EUR (≈$3.7B) | 24 | 64 | |
| 208 | 3.0B USD | 24 | 11 | |
| 209 | 3.4B USD | 23 | 17 | |
| 210 | 4.0B USD | 23 | 56 | |
| 211 | 2.2B USD | 23 | 36 | |
| 212 | 4.8B USD | 22 | 52 | |
| 213 | 25.3B HKD (≈$3.2B) | 22 | 57 | |
| 214 | 5.9B USD | 21 | 39 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score